Nicotinamide Mononucleotide Sustained-release Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nicotinamide Mononucleotide Sustained-release Tablets, covering 2025-07-08 to 2025-07-08. Get the full timeline:
Most recent: Clinical Trial Update: The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders. [NA]